Neurocrine Biosciences, Inc.
NBIX
$118.78
$1.911.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.06% | 4.31% | 12.14% | 6.37% | 35.32% |
| Total Receivables | 14.49% | 9.06% | 15.15% | 20.79% | 15.09% |
| Inventory | 58.87% | 49.87% | 59.03% | 34.07% | 11.38% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18.71% | 14.62% | 12.48% | 19.48% | -11.22% |
| Total Current Assets | -8.95% | 7.32% | 13.74% | 11.57% | 25.56% |
|
|
|||||
| Total Current Assets | -8.95% | 7.32% | 13.74% | 11.57% | 25.56% |
| Net Property, Plant & Equipment | 70.24% | 70.46% | 125.47% | 130.05% | 135.12% |
| Long-term Investments | -- | -1.72% | -- | -- | -- |
| Goodwill | -- | -1.72% | -- | -- | -- |
| Total Other Intangibles | 6.12% | 2.82% | -1.15% | -9.21% | -7.80% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.95% | 21.92% | 19.61% | 15.04% | 18.44% |
| Total Assets | 6.20% | 14.37% | 24.11% | 26.48% | 47.15% |
|
|
|||||
| Total Accounts Payable | 26.00% | -17.48% | 2.03% | -72.63% | -75.46% |
| Total Accrued Expenses | 11.37% | 11.44% | -11.74% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -71.10% | -76.13% | -81.46% | -81.11% | 796.59% |
| Total Finance Division Other Current Liabilities | -83.10% | -84.68% | -97.01% | 31.43% | 20,237.50% |
| Total Other Current Liabilities | -83.10% | -84.68% | -97.01% | 31.43% | 20,237.50% |
| Total Current Liabilities | -26.65% | -22.46% | -37.87% | -31.59% | 90.56% |
|
|
|||||
| Total Current Liabilities | -26.65% | -22.46% | -37.87% | -31.59% | 90.56% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 76.95% | 76.19% | 192.67% | 187.54% | 179.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 50.71% | 56.35% | 96.79% | 59.44% | 191.77% |
| Total Liabilities | 6.05% | 10.75% | -3.55% | 4.70% | 60.86% |
|
|
|||||
| Common Stock & APIC | 1.42% | 7.25% | 13.63% | 13.98% | 15.01% |
| Retained Earnings | 95.34% | 118.59% | 126.61% | 87.45% | 76.48% |
| Treasury Stock & Other | 172.73% | -17.14% | 952.94% | 327.27% | 222.22% |
| Total Common Equity | 6.27% | 16.03% | 35.80% | 35.41% | 41.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.27% | 16.03% | 35.80% | 35.41% | 41.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.27% | 16.03% | 35.80% | 35.41% | 41.65% |
|
|
|||||